首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1498663

全球球囊瓣膜成形术设备市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Balloon Valvuloplasty Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年06月01日 | 出版商:

Value Market Research | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球球囊瓣膜成形术设备市场需求预计将从 2023 年的 29.7 亿美元达到近 47.5 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 5.36%。

球囊瓣膜成形术装置是用于治疗狭窄心臟瓣膜的医疗工具，通常用于扩大狭窄的心臟瓣膜（例如主动脉瓣或二尖瓣）的手术。此过程需要将带有球囊的导管穿过血管到达受影响的瓣膜。一旦就位，球囊就会膨胀以扩大瓣膜开口，改善血流并减轻症状。球囊瓣膜成形术是瓣膜置换手术的一种微创替代手术，可为某些患者提供更短的恢復时间并降低风险。它通常用于儿科心臟病学以及不适合心臟直视手术的患者。

市场动态

由于人口老化和心血管危险因子发病率的不断上升，主动脉瓣狭窄和二尖瓣关闭不全等瓣膜性心臟病的盛行率不断上升，推动了球囊瓣膜成形术设备市场的发展，推动了市场对球囊瓣膜成形术等微创治疗方案的需求。这种日益严重的疾病负担强调需要有效且侵入性较小的手术干预替代方案，从而推动市场成长。球囊瓣膜成形术设备的技术进步，包括下一代导管和输送系统的开发，提高了手术成功率和患者结果，并推动了更广泛的临床环境的采用。将球囊瓣膜成形术的适应症从传统的高风险手术患者扩展到低风险族群和老年人群，进一步扩大了市场范围和潜力。此外，增加医疗保健支出和对心血管护理基础设施的投资，特别是在新兴经济体，透过扩大球囊瓣膜成形术等先进治疗方式的可及性，有助于市场成长。此外，旨在促进市场准入并确保患者安全和护理品质的支持性报销政策和监管框架刺激了对球囊瓣膜成形术设备的市场需求。然而，潜在的併发症和手术的高成本可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球球囊瓣膜成形术设备市场的每个细分市场进行了包容性评估。球囊瓣膜成形术设备产业的成长和趋势为本研究提供了整体方法。

市场区隔

球囊瓣膜成形术设备市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

依产品类型

标准气球
切割气球
得分气球
高压气球
低压气球

按申请

主动脉瓣狭窄
肺动脉瓣狭窄

按年龄段

儿科
成人

按最终用途

医院
门诊手术中心
专科诊所
其他

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的球囊瓣膜成形术设备市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。球囊瓣膜成形术设备市场的主要参与者包括Abbott Laboratories、B. Braun Melsungen AG、Becton、Dickinson, Company、Boston Scientific Corporation、Cardinal Health Inc.、Cook Medical Inc.、Edwards Lifesciences Corporation、Innomed Medical Development Ltd. 、Jotech GmbH、Medtronic Plc、Microport Scientific Corporation、Numed Canada Inc.、NuMED Inc.、Osypka Medical GmbH、Teleflex Incorporated。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 市场吸引力分析：按产品类型
- 市场吸引力分析：依应用分类
- 按年龄组别分類的市场吸引力分析
- 按最终用途分類的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球气球瓣膜成形术设备市场分析：依产品类型

概述：按产品类型
历史与预测资料分析：按产品类型
标准气球
切割气球
得分气球
高压气球
低压气球

第 6 章：全球气球瓣膜成形术设备市场分析：依应用分类

概述：按应用
历史与预测资料分析：按应用分类
主动脉瓣狭窄
肺动脉瓣狭窄

第 7 章：全球气球瓣膜成形术设备市场分析：依年龄组

按年龄组别概述
按年龄组别进行的历史和预测资料分析
儿科
成人

第 8 章：全球气球瓣膜成形术设备市场分析：依最终用途分类

按最终用途分类的概述
按最终用途分类的历史和预测资料分析
医院
门诊手术中心
专科诊所
其他

第 9 章：全球气球瓣膜成形术设备市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：球囊瓣膜成形术设备公司的竞争格局

球囊瓣膜成形术设备市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
Abbott Laboratories

公司简介
公司收入
产品
最近的发展

B. Braun Melsungen AG

公司简介
公司收入
产品
最近的发展

Becton, Dickinson Company

公司简介
公司收入
产品
最近的发展

NuMED Inc.

公司简介
公司收入
产品
最近的发展

Osypka Medical GmbH

公司简介
公司收入
产品
最近的发展

Boston Scientific Corporation

公司简介
公司收入
产品
最近的发展

Cardinal Health Inc.

公司简介
公司收入
产品
最近的发展

Cook Medical Inc.

公司简介
公司收入
产品
最近的发展

Edwards Lifesciences Corporation

公司简介
公司收入
产品
最近的发展

Innomed Medical Development Ltd.

公司简介
公司收入
产品
最近的发展

Jotech GmbH

公司简介
公司收入
产品
最近的发展

Medtronic Plc

公司简介
公司收入
产品
最近的发展

Microport Scientific Corporation

公司简介
公司收入
产品
最近的发展

Numed Canada Inc.

公司简介
公司收入
产品
最近的发展

Teleflex Incorporated

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114760

The global demand for Balloon Valvuloplasty Devices Market is presumed to reach the market size of nearly USD 4.75 Billion by 2032 from USD 2.97 Billion in 2023 with a CAGR of 5.36% under the study period 2024-2032.

Balloon valvuloplasty devices are medical tools used to treat stenotic heart valves, typically in procedures to widen narrowed heart valves, such as the aortic or mitral valves. The process entails threading a catheter with an attached balloon through the blood vessels to the affected valve. Once in place, the balloon is inflated to enlarge the valve opening, improving blood flow and reducing symptoms. Balloon valvuloplasty is a minimally invasive alternative to valve replacement surgery, offering shorter recovery times and reduced risks for certain patients. It is commonly used in pediatric cardiology and for patients not candidates for open-heart surgery.

MARKET DYNAMICS

The balloon valvuloplasty devices market is driven by the increasing prevalence of valvular heart diseases, such as aortic stenosis and mitral regurgitation, due to aging populations and the escalating incidence of cardiovascular risk factors, drives market demand for minimally invasive treatment options like balloon valvuloplasty. This growing disease burden underscores the need for effective & less invasive alternatives to surgical interventions, fuelling market growth. Technological advancements in balloon valvuloplasty devices, including the development of next-generation catheters and delivery systems, enhance procedural success rates and patient outcomes, driving adoption across a wider range of clinical settings. Expanding indications for balloon valvuloplasty beyond traditional high-risk surgical patients to include lower-risk and elderly populations further broadens the market's scope and potential. Moreover, increasing healthcare expenditure and investments in cardiovascular care infrastructure, particularly in emerging economies, contribute to market growth by expanding access to advanced treatment modalities like balloon valvuloplasty. Furthermore, supportive reimbursement policies and regulatory frameworks aimed at facilitating market access and ensuring patient safety and quality of care stimulate market demand for balloon valvuloplasty devices. However, potential complications and the high cost of the procedure may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Balloon Valvuloplasty Devices. The growth and trends of Balloon Valvuloplasty Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Balloon Valvuloplasty Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Standard Balloon
Cutting Balloon
Scoring Balloon
High-Pressure Balloon
Low-Pressure Balloon

By Application

Aortic Valve Stenosis
Pulmonary Valve Stenosis

By Age Group

Pediatric
Adult

By End-use

Hospitals
Ambulatory Surgical Centres
Specialty Clinics
Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Balloon Valvuloplasty Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Balloon Valvuloplasty Devices market include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson, Company, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical Inc., Edwards Lifesciences Corporation, Innomed Medical Development Ltd., Jotech GmbH, Medtronic Plc, Microport Scientific Corporation, Numed Canada Inc., NuMED Inc., Osypka Medical GmbH, Teleflex Incorporated. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BALLOON VALVULOPLASTY DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Age Group
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Standard Balloon Historic and Forecast Sales By Regions
5.4. Cutting Balloon Historic and Forecast Sales By Regions
5.5. Scoring Balloon Historic and Forecast Sales By Regions
5.6. High-Pressure Balloon Historic and Forecast Sales By Regions
5.7. Low-Pressure Balloon Historic and Forecast Sales By Regions

6. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Aortic Valve Stenosis Historic and Forecast Sales By Regions
6.4. Pulmonary Valve Stenosis Historic and Forecast Sales By Regions

7. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY AGE GROUP

7.1. Overview By Age Group
7.2. Historical and Forecast Data Analysis By Age Group
7.3. Pediatric Historic and Forecast Sales By Regions
7.4. Adult Historic and Forecast Sales By Regions

8. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY END-USE

8.1. Overview By End-use
8.2. Historical and Forecast Data Analysis By End-use
8.3. Hospitals Historic and Forecast Sales By Regions
8.4. Ambulatory Surgical Centres Historic and Forecast Sales By Regions
8.5. Specialty Clinics Historic and Forecast Sales By Regions
8.6. Other Historic and Forecast Sales By Regions

9. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE BALLOON VALVULOPLASTY DEVICES COMPANIES

10.1. Balloon Valvuloplasty Devices Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF BALLOON VALVULOPLASTY DEVICES INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Abbott Laboratories
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. B. Braun Melsungen AG
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Becton, Dickinson Company
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. NuMED Inc.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Osypka Medical GmbH
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Boston Scientific Corporation
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Cardinal Health Inc.
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Cook Medical Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Edwards Lifesciences Corporation
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Innomed Medical Development Ltd.
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Jotech GmbH
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Medtronic Plc
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. Microport Scientific Corporation
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments
11.16. Numed Canada Inc.
- 11.16.1 Company Overview
- 11.16.2 Company Revenue
- 11.16.3 Products
- 11.16.4 Recent Developments
11.17. Teleflex Incorporated
- 11.17.1 Company Overview
- 11.17.2 Company Revenue
- 11.17.3 Products
- 11.17.4 Recent Developments